Shingles News and Research

RSS
Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain, or sometimes numbness or itch, in one particular location on only one side of the body.
Shingles vaccination rate soars but leaves many behind

Shingles vaccination rate soars but leaves many behind

Analysis: How a COVID-19 vaccine could cost Americans dearly

Analysis: How a COVID-19 vaccine could cost Americans dearly

Excessive blood clotting and stroke in COVID-19 patients

Excessive blood clotting and stroke in COVID-19 patients

Drugmakers tout COVID-19 vaccines to refurbish their public image

Drugmakers tout COVID-19 vaccines to refurbish their public image

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

Clinical trial launched to investigate safety and efficacy of antiviral drug for COVID-19

Clinical trial launched to investigate safety and efficacy of antiviral drug for COVID-19

Shingles vaccine appears to reduce stroke risk

Shingles vaccine appears to reduce stroke risk

Beyond burnout: Docs decry ‘moral injury’ from financial pressures of health care

Beyond burnout: Docs decry ‘moral injury’ from financial pressures of health care

Many older people in Australia are missing out on shingles vaccination

Many older people in Australia are missing out on shingles vaccination

UTHSC College of Pharmacy, Kroger Health partner to improve shingles vaccination completion rates

UTHSC College of Pharmacy, Kroger Health partner to improve shingles vaccination completion rates

Agape Clinic dermatologist felicitated for providing free, multidisciplinary care to Dallas patients

Agape Clinic dermatologist felicitated for providing free, multidisciplinary care to Dallas patients

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

Vaccinating older adults against shingles is likely cost-effective in Canada

Vaccinating older adults against shingles is likely cost-effective in Canada

Protein plays important roles in intracellular membrane trafficking in the brain

Protein plays important roles in intracellular membrane trafficking in the brain

California bill would fight deals that delay generic drugs

California bill would fight deals that delay generic drugs

New shingles vaccine reduces outbreaks of painful rash among stem cell transplant patients

New shingles vaccine reduces outbreaks of painful rash among stem cell transplant patients

Oral steroid use in patients with inflammatory diseases increases risk of infection

Oral steroid use in patients with inflammatory diseases increases risk of infection

Virus employs powerful strategy to inhibit natural killer cell function

Virus employs powerful strategy to inhibit natural killer cell function

Chickenpox vaccine lessens likelihood of pediatric shingles

Chickenpox vaccine lessens likelihood of pediatric shingles